Critical Need for International Consensus on Ototoxicity Assessment Criteria
Authors:
- 1 April 2010
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 28 (10) , 1630-1632
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Practical Grading System for Evaluating Cisplatin Ototoxicity in ChildrenJournal of Clinical Oncology, 2010
- Using Acetaminophen's Toxicity Mechanism to Enhance Cisplatin Efficacy in Hepatocarcinoma and Hepatoblastoma Cell LinesNeoplasia, 2009
- Ototoxicity in children treated for osteosarcomaPediatric Blood & Cancer, 2009
- Hearing Loss, Quality of Life, and Academic Problems in Long-term Neuroblastoma Survivors: A Report From the Children's Oncology GroupPediatrics, 2007
- Ototoxicity From Cisplatin Therapy in Childhood CancerJournal of Pediatric Hematology/Oncology, 2007
- Ototoxicity from high‐dose use of platinum compounds in patients with neuroblastomaCancer, 2006
- Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a Commonly Occurring Toxicity That May Influence Academic and Social DevelopmentJournal of Clinical Oncology, 2005
- Predicting cisplatin ototoxicity in children: the influence of age and the cumulative doseEuropean Journal of Cancer, 2004
- Risk-adapted treatment for childhood hepatoblastomaEuropean Journal of Cancer, 2004
- Cisplatin, Doxorubicin, and Delayed Surgery for Childhood Hepatoblastoma: A Successful Approach—Results of the First Prospective Study of the International Society of Pediatric OncologyJournal of Clinical Oncology, 2000